Following the results of the EMPA-REG OUTCOME trial with empagliflozin, is it possible to speak of a class effect?

Overview of attention for article published in International Journal of General Medicine, January 2017

Altmetric Badge

Mentioned by

twitter: 1 X user

Citations

dimensions_citation: 7 Dimensions

Readers on

mendeley: 76 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 1 X post from an account with 1,764 followers.

#SGLT2i EMPAREG outcomes Class Effect? #empagliflozin #canagliflozin #dapagliflozin https://t.co/GHoeIO6fs6

Reply Repost Favourite